IR Searcher

年度	タイプ	日付	売上高	営業利益	経常利益	純利益
2023-03	新規	2022-05-11	66000	7000	7000	5600
2024-03	新規	2023-05-11	73000	9100	9000	7000
2025-03	新規	2024-05-09	83000	10000	10000	7800
	修正	2024-11-05	86000(↑)	11000(↑)	11000(↑)	8500(↑)

通期四半期別

　※来期予想のグラフはQ1と表記されているがQ4である。

通期四半期別

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
予想		86000	11000	11000	8500		12.79%	12.79%	13.6%	14.3%	29.2%	9.9%
2025-03	2	42422	6459	7949	6061	137.51	15.23%	18.74%	15.7%	21.2%	44.6%	12.3%
	1	21455	3939	5459	4212	95.57	18.36%	25.44%	17.2%	32.6%	62.7%	44.5%
2024-03	4	75725	9621	8513	7731	175.39	12.71%	11.24%	10.7%	6.7%	12.3%	24.8%
	3	57919	9490	9444	8423	191.09	16.38%	16.31%	12%	11%	35.7%	40.8%
	2	36678	5327	5495	5396	122.43	14.52%	14.98%	8.8%	-9.6%	6.1%	35%
	1	18304	2970	3355	2915	66.14	16.23%	18.33%	12.3%	-0.2%	12.8%	12.1%
2023-03	4	68383	9014	7579	6195	140.26	13.18%	11.08%	14.9%	41.6%	27.7%	56.4%
	3	51729	8550	6957	5980	135.31	16.53%	13.45%	14.7%	55.6%	24%	47.9%
	2	33712	5894	5182	3998	90.41	17.48%	15.37%	17.9%	120.6%	66.3%	89%
	1	16305	2977	2974	2601	58.71	18.26%	18.24%	20.3%	137.8%	42.9%	84.6%
2022-03	4	59532	6366	5935	3961	87.76	10.69%	9.97%	12.8%	83.2%	85%	26%
	3	45104	5495	5613	4043	89.33	12.18%	12.44%	11.7%	41.6%	57.6%	9.2%
	2	28606	2672	3116	2115	46.65	9.34%	10.89%	12.1%	67.2%	138.4%	52.4%
	1	13548	1251	2081	1408	30.91	9.23%	15.36%	6.4%	18.3%	229.1%	44.8%
2021-03	4	55442	3442	3175	3119	67.72	6.21%	5.73%	-8.2%	-15.9%	-18.2%	6.6%
	3	42374	3856	3538	3686	79.83	9.1%	8.35%	-8.5%	14%	14.6%	57.5%
	2	26809	1598	1307	1388	30.05	5.96%	4.88%	-11.6%	-8.1%	-19.7%	12.9%
	1	13331	1060	634	974	21.05	7.95%	4.76%	-11.8%	-20.3%	-59.3%	-15%
2020-03	4	60426	4094	3879	2925	62.62	6.78%	6.42%	-2.3%	9.6%	17.7%	-15.3%
	3	46303	3382	3086	2339	49.98	7.3%	6.66%	-1.9%	10.5%	9.5%	-19.3%
	2	30317	1738	1628	1230	26.16	5.73%	5.37%	-0.5%	-16%	-15%	-46%
	1	15113	1329	1556	1146	24.14	8.79%	10.3%	-1%	-18.6%	-10.6%	-48.9%
2019-03	4	61831	3737	3295	3454	69.56	6.04%	5.33%	-4.2%	-22.6%	-35.2%	-16.9%
	3	47215	3061	2819	2900	57.96	6.48%	5.97%	-4.9%	-33.3%	-42.3%	-26.7%
	2	30483	2069	1914	2280	45.4	6.79%	6.28%	-6%	-13.5%	-24.5%	7.2%

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
予想	残	43578	4541	3051	2439	―	―	―	―	―	―
2025-03	2	20967	2520	2490	1849	41.94	12.02%	11.88%	14.11%	6.92%	16.36%	-25.47%
	1	21455	3939	5459	4212	95.57	18.36%	25.44%	17.2%	32.6%	62.7%	44.5%
2024-03	4	17806	131	-931	-692	-15.7	0.74%	―	6.92%	-71.77%	―	―
	3	21241	4163	3949	3027	68.66	19.6%	18.59%	17.89%	56.74%	122.48%	52.72%
	2	18374	2357	2140	2481	56.29	12.83%	11.65%	5.56%	-19.2%	-3.08%	77.59%
	1	18304	2970	3355	2915	66.14	16.23%	18.33%	12.3%	-0.2%	12.8%	12.1%
2023-03	4	16654	464	622	215	4.95	2.79%	3.73%	15.43%	-46.73%	93.17%	―
	3	18017	2656	1775	1982	44.9	14.74%	9.85%	9.21%	-5.92%	-28.91%	2.8%
	2	17407	2917	2208	1397	31.7	16.76%	12.68%	15.6%	105.28%	113.33%	97.6%
	1	16305	2977	2974	2601	58.71	18.26%	18.24%	20.3%	137.8%	42.9%	84.6%
2022-03	4	14428	871	322	-82	-1.57	6.04%	2.23%	10.41%	-310.39%	-188.71%	-85.54%
	3	16498	2823	2497	1928	42.68	17.11%	15.14%	5.99%	25.02%	11.92%	-16.1%
	2	15058	1421	1035	707	15.74	9.44%	6.87%	11.72%	164.13%	53.79%	70.77%
	1	13548	1251	2081	1408	30.91	9.23%	15.36%	6.4%	18.3%	229.1%	44.8%
2021-03	4	13068	-414	-363	-567	-12.11	―	―	-7.47%	-158.15%	-145.78%	-196.76%
	3	15565	2258	2231	2298	49.78	14.51%	14.33%	-2.63%	37.35%	53.02%	107.21%
	2	13478	538	673	414	9	3.99%	4.99%	-11.35%	31.54%	834.72%	392.86%
	1	13331	1060	634	974	21.05	7.95%	4.76%	-11.8%	-20.3%	-59.3%	-15%
2020-03	4	14123	712	793	586	12.64	5.04%	5.61%	-3.37%	5.33%	66.6%	5.78%
	3	15986	1644	1458	1109	23.82	10.28%	9.12%	-4.46%	65.73%	61.1%	78.87%
	2	15204	409	72	84	2.02	2.69%	0.47%	-0.13%	-6.41%	-58.38%	133.33%
	1	15113	1329	1556	1146	24.14	8.79%	10.3%	-1%	-18.6%	-10.6%	-48.9%
2019-03	4	14616	676	476	554	11.6	4.63%	3.26%	-2.06%	178.19%	139.2%	174.26%
	3	16732	992	905	620	12.56	5.93%	5.41%	-2.9%	-54.79%	-61.59%	-66.06%
	2	15224	437	173	36	―	2.87%	1.14%	-7.41%	-75.67%	-90.75%	-97.55%

4559 ゼリア新薬工業 企業サイト Yahooファイナンス 日経新聞 株探 四季報

4559 ゼリア新薬工業　企業サイト　　　Yahooファイナンス　日経新聞　株探　四季報